GMP & SHE

We develop solid, semi-solid and liquid formulations for oral, dermal and inhalative use. In doing so, we also offer the development of these dosage forms with highly effective category G3a (OEB 3) and G3b (OEB 4) substances.

Handling sensitive and hazardous substances requires special protection. We meet this challenge by applying approved and innovative protection concepts.

Contact: Dr. Alexandra Keilbach-Bermann
Head of Drug Development and Production / Head of Quality
Email: a.keilbach-bermann(at)hwi-group.de
Phone: +49 7805 401-502

Pressurized air gauge in the technological laboratory
 

We use cookies to optimise the design of our websites. By continuing your visit on the website, you consent to the use of cookies. Find out more about our cookies and how we use them.

OK